Cinclus Pharma
IPOClinical Stage Pharma From Sweden
Cinclus Pharma is a biotech company in Stockholm, Sweden, founded in 2014.
- Headquarters
- Stockholm, Stockholm
- Employees
- 1–10
- Founded
- 2014
- Website
- cincluspharma.com
- Type
- Public
About
Cinclus Pharma develops small molecules for treating gastric acid-related diseases. Its lead candidate, linaprazan glurate, is being developed for severe gastroesophageal reflux disease (GERD), addressing patients inadequately treated by traditional PPI-based drugs. Its management team has drug-development experience in acid inhibition.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
- Backend ×1
- Frontend ×1
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Companies in related industries
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cinclus-pharma"><img src="https://indexed.vc/api/badge/company/cinclus-pharma" alt="Cinclus Pharma on Indexed.vc" width="260" height="76" /></a>
